Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market
Holding APRE?
Track your performance easily

Aprea Therapeutics (APRE) Technical Analysis

430 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Aprea Therapeutics Inc’s (APRE) Moving Averages Convergence Divergence (MACD) indicator is -0.16, suggesting Aprea Therapeutics Inc is a Buy.
Aprea Therapeutics Inc’s (APRE) 20-Day exponential moving average is 3.30, while Aprea Therapeutics Inc’s (APRE) share price is $2.92, making it a Sell.
Aprea Therapeutics Inc’s (APRE) 50-Day exponential moving average is 3.60, while Aprea Therapeutics Inc’s (APRE) share price is $2.92, making it a Sell.

Aprea Therapeutics (APRE) Pivot Points

Sep 20, 2024, 12:19 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.58
2.74
2.87
3.04
3.17
3.33
3.47
Fibonacci
2.74
2.85
2.92
3.04
3.15
3.22
3.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aprea Therapeutics (APRE) Moving Averages

Sep 20, 2024, 12:19 AM
Period
Simple
Exponential
MA5
3.10Sell
3.05Sell
MA10
3.20Sell
3.17Sell
MA20
3.37Sell
3.30Sell
MA50
3.59Sell
3.60Sell
MA100
4.16Sell
4.04Sell
MA200
4.92Sell
4.47Sell
Aprea Therapeutics Inc’s (APRE) 10-Day exponential moving average is 3.17, while Aprea Therapeutics Inc’s (APRE) share price is $2.92, making it a Sell.
Aprea Therapeutics Inc’s (APRE) 100-Day exponential moving average is 4.04, while Aprea Therapeutics Inc’s (APRE) share price is $2.92, making it a Sell.
Aprea Therapeutics Inc’s (APRE) stock price is $2.92 and Aprea Therapeutics Inc’s (APRE) 50-day simple moving average is 3.59, creating a Sell signal.
Aprea Therapeutics Inc’s (APRE) stock price is $2.92 and Aprea Therapeutics Inc’s (APRE) 100-day simple moving average is 4.16, creating a Sell signal.
Aprea Therapeutics Inc’s (APRE) stock price is $2.92 and Aprea Therapeutics Inc’s (APRE) 200-day simple moving average is 4.92, creating a Sell signal.

Aprea Therapeutics (APRE) Technical Indicators

Sep 20, 2024, 12:19 AM
Name
Value
Implied Action
RSI (14)
32.08
Neutral
STOCH (9,6)
12.02
Buy
STOCHRSI (14)
10.56
Buy
MACD (12,26)
-0.16
Buy
ADX (14)
37.55
Neutral
Williams %R
-100.00
Buy
CCI (14)
-175.65
Buy
ATR (14)
0.24
-
Ultimate Oscillator
43.30
Neutral
ROC
-18.29
Sell
Aprea Therapeutics Inc’s (APRE) Relative Strength Index (RSI) is 32.08, creating a Neutral signal.
Aprea Therapeutics Inc’s (APRE) Trend Strength Indicator (ADX) is 37.55, creating a Neutral signal.
Aprea Therapeutics Inc’s (APRE) Commodity Channel Index (CCI) is -175.65, creating a Buy signal.
Aprea Therapeutics Inc’s (APRE) Price Rate of Change (ROC) is -18.29, creating a Sell signal.

FAQ

Is APRE a Buy, Hold, or Sell?
Based on APRE’s technical indicators, APRE is a Sell.
    What is APRE’s RSI (14)?
    APRE’s RSI (14) is 32.08, which suggests APRE is a Neutral.
      What is APRE’s MACD?
      APRE’s MACD is -0.16, which suggests APRE is a Buy.
        What is APRE’s 5-day moving average?
        APRE’s 5-day moving average is 3.10, which suggests APRE is a Sell.
          What is APRE’s 20-day moving average?
          APRE 20-day moving average is 3.37, which suggests APRE is a Sell.
            What is APRE’s 50-day moving average?
            APRE’s 50-day moving average is 3.59, which suggests APRE is a Sell.
              What is APRE’s 200-day moving average?
              APRE’s 200-day moving average is 4.92, which suggests APRE is a Sell.
                What is APRE’s Williams % R (14)?
                APRE’s Williams % R (14) is -100.00, which suggests APRE is a Buy.
                  What is APRE’s CCI (14)?
                  APRE’s CCI (14) is -175.65, which suggests APRE is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis